Congratulations to the Roth Lab for having the NIMH grant that funds the Psychoactive Drug Screening Program renewed for another 5 years!
Bryan Roth has directed this program since 1998, and with his team of dedicated and talented scientists, has screened more than 50,000 compounds against more than 500 targets, representing the largest single collection of GPCR’s, channels and transporters. The screen is done for NIH funded investigators at no cost.
